We are thrilled to share that Dr. Art Hsing-Mao Chu, CEO of T-E Meds, will be presenting at the world’s longest-standing and most authoritative ADC forum.
⏰Time: Monday, November 3, 2025 | 11:00 – 11:30 AM
📍Presentation Title: Developing Efficacious, Stable & Safe High-DAR Mono & Dual-Payload ADCs via Modular Multi-Arm Drug Bundle Technology & Flexible Conjugation Strategies
💡In addition, T-E Meds has been shortlisted for the “Best New Drug Developer 2025” award at the 12th Annual World ADC Awards. The winner will be announced at the gala dinner on November 5th—stay tuned and celebrate this exciting milestone with us!
